Keywords: rx, promo, spend, topped, billion, first-half, dtc
US Rx promo spend topped $8 billion in first-half 2000, with DTC up 44.5%
Article | 23 October 2000
In the USA, spending by pharmaceutical companies on promotion towardphysicians and consumers totaled more than $8 billion during January-June 2000, up 14.3% on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
